Ambulatory Pediatrics
Volume 5, Issue 3 , Pages 157-164 , May 2005

Provider Adoption of Pneumococcal Conjugate Vaccine and the Impact of Vaccine Shortages

  • Matthew F. Daley, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Matthew F. Daley, MD, 1056 E 19th Ave, B032, Denver, CO 80218
    • ,
  • Lori A. Crane, PhD, MPH

      Affiliations

    • From the Departments of Pediatrics (Drs Daley, Berman, and Kempe) and Preventive Medicine and Biometrics (Dr Crane) and the Colorado Health Outcomes Program (Ms Beaty), University of Colorado Health Sciences Center, Denver, Colo; the Children's Outcomes Research Program (Drs Daley, Crane, Berman, Kempe, Ms Barrow, and Ms Pearson), The Children's Hospital, Denver, Colo; and the National Immunization Program (Mr Stevenson), Centers for Disease Control and Prevention, Atlanta, Ga
    • ,
  • Brenda L. Beaty, MSPH

      Affiliations

    • From the Departments of Pediatrics (Drs Daley, Berman, and Kempe) and Preventive Medicine and Biometrics (Dr Crane) and the Colorado Health Outcomes Program (Ms Beaty), University of Colorado Health Sciences Center, Denver, Colo; the Children's Outcomes Research Program (Drs Daley, Crane, Berman, Kempe, Ms Barrow, and Ms Pearson), The Children's Hospital, Denver, Colo; and the National Immunization Program (Mr Stevenson), Centers for Disease Control and Prevention, Atlanta, Ga
    • ,
  • Jennifer Barrow, MSPH

      Affiliations

    • From the Departments of Pediatrics (Drs Daley, Berman, and Kempe) and Preventive Medicine and Biometrics (Dr Crane) and the Colorado Health Outcomes Program (Ms Beaty), University of Colorado Health Sciences Center, Denver, Colo; the Children's Outcomes Research Program (Drs Daley, Crane, Berman, Kempe, Ms Barrow, and Ms Pearson), The Children's Hospital, Denver, Colo; and the National Immunization Program (Mr Stevenson), Centers for Disease Control and Prevention, Atlanta, Ga
    • ,
  • Kellyn Pearson, MSN

      Affiliations

    • From the Departments of Pediatrics (Drs Daley, Berman, and Kempe) and Preventive Medicine and Biometrics (Dr Crane) and the Colorado Health Outcomes Program (Ms Beaty), University of Colorado Health Sciences Center, Denver, Colo; the Children's Outcomes Research Program (Drs Daley, Crane, Berman, Kempe, Ms Barrow, and Ms Pearson), The Children's Hospital, Denver, Colo; and the National Immunization Program (Mr Stevenson), Centers for Disease Control and Prevention, Atlanta, Ga
    • ,
  • John M. Stevenson, MA

      Affiliations

    • From the Departments of Pediatrics (Drs Daley, Berman, and Kempe) and Preventive Medicine and Biometrics (Dr Crane) and the Colorado Health Outcomes Program (Ms Beaty), University of Colorado Health Sciences Center, Denver, Colo; the Children's Outcomes Research Program (Drs Daley, Crane, Berman, Kempe, Ms Barrow, and Ms Pearson), The Children's Hospital, Denver, Colo; and the National Immunization Program (Mr Stevenson), Centers for Disease Control and Prevention, Atlanta, Ga
    • ,
  • Stephen Berman, MD

      Affiliations

    • From the Departments of Pediatrics (Drs Daley, Berman, and Kempe) and Preventive Medicine and Biometrics (Dr Crane) and the Colorado Health Outcomes Program (Ms Beaty), University of Colorado Health Sciences Center, Denver, Colo; the Children's Outcomes Research Program (Drs Daley, Crane, Berman, Kempe, Ms Barrow, and Ms Pearson), The Children's Hospital, Denver, Colo; and the National Immunization Program (Mr Stevenson), Centers for Disease Control and Prevention, Atlanta, Ga
    • ,
  • Allison Kempe, MD, MPH

      Affiliations

    • From the Departments of Pediatrics (Drs Daley, Berman, and Kempe) and Preventive Medicine and Biometrics (Dr Crane) and the Colorado Health Outcomes Program (Ms Beaty), University of Colorado Health Sciences Center, Denver, Colo; the Children's Outcomes Research Program (Drs Daley, Crane, Berman, Kempe, Ms Barrow, and Ms Pearson), The Children's Hospital, Denver, Colo; and the National Immunization Program (Mr Stevenson), Centers for Disease Control and Prevention, Atlanta, Ga

Received 16 August 2004 ,Accepted 28 November 2004.

REFERENCES 

  1. Centers for Disease Control and Prevention. . Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP) . MMWR . 1991;40:1–25
  2. Yusuf HR , Coronado VG , Averhoff FA , et al.   Progress in coverage with hepatitis B vaccine among US children, 1994–1997 . Am J Public Health . 1999;89:1684–1689
  3. Centers for Disease Control and Prevention. . National, state, and urban area vaccination coverage levels among children aged 19–35 months—United States, 1997 . MMWR . 1998;47:547–554
  4. Centers for Disease Control and Prevention. . National vaccination coverage levels among children aged 19–35 months—United States, 1998 . MMWR . 1999;48:829–830
  5. Centers for Disease Control and Prevention. . National, state, and urban area vaccination coverage levels among children aged 19–35 months—United States, 1999 . MMWR . 2000;49:585–589
  6. Centers for Disease Control and Prevention. . National, state, and urban area vaccination coverage levels among children aged 19–35 months—United States, 2000 . MMWR . 2001;50:637–641
  7. Centers for Disease Control and Prevention. . Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP) . MMWR . 1996;45:1–36
  8. Centers for Disease Control and Prevention. . National, state, and urban area vaccination coverage levels among children aged 19–35 months—United States, 2001 . MMWR . 2002;51:664–666
  9. Centers for Disease Control and Prevention. . National, state, and urban area vaccination levels among children aged 19–35 months—United States, 2002 . MMWR . 2003;52:728–732
  10. Centers for Disease Control and Prevention. . Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) . MMWR . 1999;48:1–20
  11. Centers for Disease Control and Prevention. . Intussusception among recipients of rotavirus vaccine—United States, 1998– 1999 . MMWR . 1999;48:577–581
  12. Centers for Disease Control and Prevention. . Withdrawal of rotavirus vaccine recommendation . MMWR . 1999;48:1007
  13. Sansom SL , Barker L , Corso PS , et al.   Rotavirus vaccine and intussusception: how much risk will parents in the United States accept to obtain vaccine benefits? . Am J Epidemiol . 2001;154:1077–1085
  14. McPhillips HA , Davis RL , Marcuse EK , Taylor JA . The rotavirus vaccine's withdrawal and physicians' trust in vaccine safety mechanisms . Arch Pediatr Adolesc Med . 2001;155:1051–1056
  15. Iwamoto M , Saari TN , McMahon SR , et al.   A survey of pediatricians on the reintroduction of a rotavirus vaccine . Pediatrics . 2003;112:e6
  16. Centers for Disease Control and Prevention. . Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) . MMWR . 2000;49:1–35
  17. American Academy of Pediatrics. . Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis . Pediatrics . 2000;106:362–366
  18. Zimmerman RK . Pneumococcal conjugate vaccine for young children . Am Fam Physician . 2001;63:1991–1998
  19. Schaffer SJ , Szilagyi PG , Shone LP , et al.   Physician perspectives regarding pneumococcal conjugate vaccine . Pediatrics . 2002;110:e68
  20. Davis MM , Ndiaye SM , Freed GL , Clark SJ . One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians . J Am Board Fam Pract . 2003;16:363–371
  21. Davis MM , Andreae M , Freed GL . Physicians' early challenges related to the pneumococcal conjugate vaccine . Ambul Pediatr . 2001;1:302–305
  22. Lieu TA , Finkelstein JA , Adams MM , et al.   Pediatricians' views on financial barriers and values for pneumococcal vaccine for children . Ambul Pediatr . 2002;2:358–366
  23. Freed GL , Davis MM , Andreae MC , et al.   Reimbursement for Prevnar: a modern-day version of Hercules and the Hydra . Pediatrics . 2002;110:399–400
  24. Whitney CG , Farley MM , Hadler J , et al.   Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine . N Engl J Med . 2003;348:1737–1746
  25. Kaplan SL , Mason EO , Wald ER , et al.   Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine . Pediatrics . 2004;113:443–449
  26. Flannery B , Schrag S , Bennett NM , et al.   Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections . JAMA . 2004;291:2197–2203
  27. Black S , Shinefield H , Baxter R , et al.   Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente . Pediatr Infect Dis J . 2004;23:485–489
  28. Centers for Disease Control and Prevention. . Decreased availability of pneumococcal conjugate vaccine . MMWR . 2001;50:783–784
  29. Centers for Disease Control and Prevention. . Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage—Advisory Committee on Immunization Practices . MMWR . 2001;50:1140–1142
  30. Centers for Disease Control and Prevention. . Limited supply of pneumococcal conjugate vaccine . MMWR . 2003;52:1234
  31. Centers for Disease Control and Prevention. . Updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose . MMWR . 2004;53:177–178
  32. Centers for Disease Control and Prevention. . Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000–01 influenza season. Advisory Committee on Immunization Practices . MMWR . 2000;49:619–622
  33. Centers for Disease Control and Prevention. . Update on the supply of tetanus and diphtheria toxoids and of diphtheria and tetanus toxoids and acellular pertussis vaccine . MMWR . 2001;50:189–190
  34. Centers for Disease Control and Prevention. . Shortage of varicella and measles, mumps and rubella vaccines and interim recommendations from the Advisory Committee on Immunization Practices . MMWR . 2002;51:190–191
  35. Centers for Disease Control and Prevention. . Update: supply of diphtheria and tetanus toxoids and acellular pertussis vaccine . MMWR . 2002;50:1159
  36. Renfrew BL , Kempe A , Lowery NE , et al.   The impact of immunization record aggregation on up-to-date rates—implications for immunization registries in rural areas . J Rural Health . 2001;17:122–126
  37. Kempe A , Steiner JF , Renfrew BL , et al.   How much does a regional immunization registry increase documented immunization rates at primary care sites in rural Colorado? . Ambul Pediatr . 2001;1:213–216
  38. Daley MF , Steiner JF , Brayden RM , et al.   Immunization registry-based recall for a new vaccine . Ambul Pediatr . 2002;2:438–443
  39. Janz NK , Champion VL , Strecher VJ . The Health Belief Model . In: Glanz K , Rimer BK , Lewis FM editor. Health Behavior and Health Education: Theory, Research, and Practice . 3rd Edition ed.. San Francisco, Calif: Jossey-Bass; 2002;p. 45–66
  40. Zimmerman RK , Bradford BJ , Janosky JE , et al.   Barriers to measles and pertussis immunization: the knowledge and attitudes of Pennsylvania primary care physicians . Am J Prev Med . 1997;13:89–97
  41. Zimmerman RK , Schlesselman JJ , Mieczkowski TA , et al.   Physician concerns about vaccine adverse effects and potential litigation . Arch Pediatr Adolesc Med . 1998;152:12–29
  42. Zimmerman RK , Mieczkowski TA , Mainzer HM , et al.   Understanding physician agreement with varicella immunization guidelines . Prev Med . 2002;35:135–142
  43. Ehresmann KR , Mills WA , Loewenson PR , Moore KA . Attitudes and practices regarding varicella vaccination among physicians in Minnesota: implications for public health and provider education . Am J Public Health . 2000;90:1917–1920
  44. Cooper A , Yusuf H , Rodewald L , et al.   Attitudes, practices, and preferences of pediatricians regarding initiation of hepatitis B immunization at birth . Pediatrics . 2001;108:e98
  45. Freed GL , Davis MM , Clark SJ . Variation in public and private supply of pneumococcal conjugate vaccine during a shortage . JAMA . 2003;289:575–578
  46. Centers for Disease Control and Prevention. . Pneumococcal conjugate vaccine shortage resolved . MMWR . 2003;52:446–447
  47. Nunnally JC . Assessment of reliability . In: Psychometric Theory . 2nd ed.. New York, NY: McGraw-Hill Inc; 1978;p. 225–255
  48. Schafer JL . Analysis of Incomplete Multivariate Data . London, UK: Chapman & Hall; 1997;
  49. Zhang J , Yu KF . What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes . JAMA . 1998;280:1690–1691
  50. Forthofer R , Lee E . Introduction to biostatistics: a guide to design, analysis, and discovery . San Diego, Calif: Academic Press Inc; 1995;
  51. Freed GL , Bordley WC , Clark SJ , Konrad TR . Universal hepatitis B immunization of infants: reactions of pediatricians and family physicians over time . Pediatrics . 1994;93:747–751
  52. Freed GL , Freeman VA , Clark SJ , et al.   Pediatrician and family physician agreement with and adoption of universal hepatitis B immunization . J Fam Pract . 1996;42:587–592
  53. Zimmerman RK , Mieczkowski TA . How important is early childhood hepatitis B vaccination? A survey of primary care physicians . J Fam Pract . 1998;47:370–374
  54. Newman RD , Taylor JA . Reactions of pediatricians to the recommendation for universal varicella vaccination . Arch Pediatr Adolesc Med . 1998;152:792–796
  55. Schaffer SJ , Bruno S . Varicella immunization practices and the factors that influence them . Arch Pediatr Adolesc Med . 1999;153:357–362
  56. Hueston WJ , Meade RL , Mainous AG . Childhood immunization practices of primary care physicians . Arch Fam Med . 1992;1:225–228
  57. Deutchman M , Brayden R , Siegel C , et al.   Childhood immunization practices in rural family and general practices: current practices, perceived barriers and strategies for improvement . Ambul Child Health . 2000;6:181–189
  58. Pelton SI , Dagan R , Gaines BM , et al.   Pneumococcal conjugate vaccines: proceedings from an interactive symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy . Vaccine . 2003;21:1562–1571
  59. Asch DA , Jedrziewski MK , Christakis NA . Response rates to mail surveys published in medical journals . J Clin Epidemiol . 1997;50:1129–1136
  60. Cummings SM , Savitz LA , Konrad TR . Reported response rates to mailed physician questionnaires . Health Serv Res . 2001;35:1347–1355

 Presented in part at the Pediatric Academic Societies' Annual Meeting, Seattle, Wash, May 2003.

PII: S1530-1567(05)60195-5

doi: 10.1367/A04-142R.1

Ambulatory Pediatrics
Volume 5, Issue 3 , Pages 157-164 , May 2005

Article Tools

* Image Usage & Resolution